Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA Posted on February 10, 2022 By Becky Carter David B. Finlay, Jamie J. Manning, Mikkel Søes Ibsen, Christa E. Macdonald, Monica Patel, Jonathan A. Javitch, Samuel D. Banister, and Michelle Glass ACS Chemical Neuroscience; 10(10); 2019 Access article Cannabis and Cannabinoids, Chemistry, Seized Drugs/Controlled Substances, Toxicology